Accelerated Bone Loss in Transgenic Mice Expressing Constitutively Active TGF-β Receptor Type I

Area of Science:

• Skeletal Biology
• Bone Metabolism
• Cell Signaling

Background:

• Transforming growth factor beta (TGF-β) is crucial for cell communication in the bone microenvironment.
• Dysregulation of TGF-β signaling can impact bone homeostasis and lead to skeletal disorders.

Purpose of the Study:

• To investigate the skeletal consequences of constitutively active TGF-β receptor type I (TβRI) in a mouse model.
• To elucidate the cellular and molecular mechanisms underlying TGF-β-induced bone loss.

Main Methods:

• Generated transgenic mice (Mx1;TβRI) with inducible and active TβRI expression.
• Utilized micro-computed tomography (μCT) and histomorphometry for bone structure analysis.
• Performed gene expression (qPCR) and protein analysis (Western blot) on bone cells and tissues.

Main Results:

• Mx1;TβRI mice exhibited reduced cortical thickness and cancellous bone volume in femurs and mandibles.
• Increased osteoclast number and differentiation, coupled with decreased osteoblast number and function, were observed.
• Key gene expression changes indicated altered osteoclastogenesis, osteoblastogenesis, and suppressed Hedgehog signaling pathways.

Conclusions:

• Constitutive TβRI activation causes osteopenia in mice by disrupting the balance between bone resorption and formation.
• The study suggests that TGF-β signaling may suppress Hedgehog pathways, contributing to bone loss.
• These findings highlight TGF-β as a potential therapeutic target for bone diseases characterized by osteopenia.